[CADL] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
30-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 57.26%
YoY- -152.71%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 31 31 31 31 31 31 31 0.00%
PBT 1,596 -16,162 -17,080 -4,478 -10,478 -2,554 -2,876 -
Tax 12 14 15 191 4,504 154 413 -90.48%
NP 1,596 -16,162 -17,080 -4,478 -10,478 -2,554 -2,876 -
Tax Rate -0.75% - - - - - - -
Total Cost -1,565 16,193 17,111 4,509 10,509 2,585 2,907 -
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 5,148.39 -52,135.48 -55,096.77 -14,445.16 -33,800.00 -8,238.71 -9,277.42 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS 0.07 -0.69 -0.69 -0.24 -0.56 -0.14 -0.15 -
EPS Diluted 0.07 -0.69 -0.69 -0.24 -0.56 -0.14 -0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.